Item

ADSCaN: A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non-Small Cell Lung Cancer. (ISRCTN47674500)

Hatton, M. Q. F.
; 
Cantley, C.
; 
Faivre-Finn, C.
; 
Peedell, C.
; 
Pope, A.
; 
Fenwick, J.
; 
Simoes, R.
; 
Rawlinson, J.
; 
Rai, D.
; 
McCarney, E.
Citations
Altmetric:
Abstract
Authors
Hatton, M. Q. F.
Cantley, C.
Faivre-Finn, C.
Peedell, C.
Pope, A.
Fenwick, J.
Simoes, R.
Rawlinson, J.
Rai, D.
McCarney, E.
Affiliation
Weston Pk Hosp, Clin Oncol, Sheffield, England Univ Glasgow, Glasgow Oncol Clin Trials Unit, Glasgow, Scotland Univ Manchester, Christie NHS Fdn Trust, Manchester, England JamMiddlesbroughes Cook Univ Hosp, Clin Oncol, Middlesbrough, England Clatterbridge Canc Ctr, Clin Oncol, Liverpool, England Clatterbridge Canc Ctr, Dept Phys, Liverpool, England Mt Vernon Hosp, Natl Radiotherapy Trials Qual Assurance RTTQA Grp, London, England WM Canc Alliance LC EAG, ELF LC patient Advisory Grp, Birmingham, England
Description
Date
2025
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Hatton MQF, Cantley C, Faivre-Finn C, Peedell C, Pope A, Fenwick J, et al. ADSCaN: A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non-Small Cell Lung Cancer. (ISRCTN47674500). RADIOTHERAPY AND ONCOLOGY. 2025 MAY;206. PubMed PMID: WOS:001509185700042. English.
Journal Title
Journal ISSN
Volume Title
URI
https://christie.openrepository.com/handle/10541/627486
Embedded videos